The schema newly classified 15.4% of persons without airflow obstruction as having COPD by minor diagnostic category, Surya P ...

Using imaging and respiratory symptoms, researchers identified up to 15.4% of individuals without airflow obstruction as ...

Current recommendations for diagnosis of COPD in patients with respiratory symptoms require detection of airflow obstruction ...

As monsoon arrives, respiratory ailments tend to spike due to humidity, sudden weather shifts, and increased allergens. For ...

Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male presentation.

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

The likelihood for avoidance of five clinically important outcomes in patients with COPD and type 2 inflammation was greater ...

Learn the warning signs that differentiate harmless coughs from those requiring medical attention, including timeline ...

Pharma group GSK has announced that US regulators have approved for use its Nucala treatment for adults with chronic ...